Genetic Epidemiology, Psychiatric Genetics, Asthma Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
24949998
TITLE
Assessment of PALB2 as a candidate melanoma susceptibility gene.
ABSTRACT
Partner and localizer of BRCA2 (PALB2) interacts with BRCA2 to enable double strand break repair through homologous recombination. Similar to BRCA2, germline mutations in PALB2 have been shown to predispose to Fanconi anaemia as well as pancreatic and breast cancer. The PALB2/BRCA2 protein interaction, as well as the increased melanoma risk observed in families harbouring BRCA2 mutations, makes PALB2 a candidate for melanoma susceptibility. In order to assess PALB2 as a melanoma predisposition gene, we sequenced the entire protein-coding sequence of PALB2 in probands from 182 melanoma families lacking pathogenic mutations in known high penetrance melanoma susceptibility genes: CDKN2A, CDK4, and BAP1. In addition, we interrogated whole-genome and exome data from another 19 kindreds with a strong family history of melanoma for deleterious mutations in PALB2. Here we report a rare known deleterious PALB2 mutation (rs118203998) causing a premature truncation of the protein (p.Y1183X) in an individual who had developed four different cancer types, including melanoma. Three other family members affected with melanoma did not carry the variant. Overall our data do not support a case for PALB2 being associated with melanoma predisposition.
DATE PUBLISHED
2014
HISTORY
PUBSTATUS PUBSTATUSDATE
ecollection 2014
received 2014/03/19
accepted 2014/05/27
epublish 2014/06/20
entrez 2014/06/21 06:00
pubmed 2014/06/21 06:00
medline 2014/06/21 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Aoude LG Aoude Lauren G LG QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia.
Xu M Xu Mai M National Cancer Institute, Bethesda, Maryland, United States of America.
Zhao ZZ Zhao Zhen Zhen ZZ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Kovacs M Kovacs Michael M National Cancer Institute, Bethesda, Maryland, United States of America.
Palmer JM Palmer Jane M JM QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Johansson P Johansson Peter P QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Symmons J Symmons Judith J QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Trent JM Trent Jeffrey M JM Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Martin NG Martin Nicholas G NG QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Montgomery GW Montgomery Grant W GW QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Brown KM Brown Kevin M KM National Cancer Institute, Bethesda, Maryland, United States of America; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Hayward NK Hayward Nicholas K NK QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
INVESTIGATORS
JOURNAL
VOLUME: 9
ISSUE: 6
TITLE: PloS one
ISOABBREVIATION: PLoS ONE
YEAR: 2014
MONTH:
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1932-6203
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: PLoS One
COUNTRY: United States
ISSNLINKING: 1932-6203
NLMUNIQUEID: 101285081
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Melanoma Res. 1996 Apr;6(2):155-65 8791274
Cites Genet Epidemiol. 1999;16(1):40-53 9915566
Cites J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6 10433620
Cites Mol Cell. 2006 Jun 23;22(6):719-29 16793542
Cites Cancer Res. 2006 Oct 15;66(20):9818-28 17047042
Cites Nat Genet. 2007 Feb;39(2):165-7 17200668
Cites Nat Genet. 2007 Feb;39(2):162-4 17200671
Cites Nat Genet. 2007 Feb;39(2):159-61 17200672
Cites Nature. 2007 Mar 15;446(7133):316-9 17287723
Cites Breast Cancer Res. 2007;9(6):R83 18053174
Cites Prostate. 2008 May 1;68(6):675-8 18288683
Cites Breast Cancer Res Treat. 2009 Feb;113(3):545-51 18302019
Cites Breast Cancer Res Treat. 2009 Apr;114(3):457-62 18446436
Cites Science. 2009 Apr 10;324(5924):217 19264984
Cites Bioinformatics. 2009 Jul 15;25(14):1754-60 19451168
Cites Bioinformatics. 2009 Aug 15;25(16):2078-9 19505943
Cites Gastroenterology. 2009 Sep;137(3):1183-6 19635604
Cites Clin Genet. 2009 Nov;76(5):421-6 19863560
Cites Fam Cancer. 2009;8(4):347-53 19333784
Cites BMC Med Genet. 2010;11:20 20122277
Cites Fam Cancer. 2010 Jun;9(2):181-5 19763884
Cites Clin Genet. 2010 Nov;78(5):490-4 20412113
Cites Breast Cancer Res Treat. 2011 Apr;126(3):825-8 21184274
Cites Cancer Res. 2011 Mar 15;71(6):2222-9 21285249
Cites Fam Cancer. 2011 Jun;10(2):315-7 21153565
Cites Fam Cancer. 2011 Jun;10(2):225-31 21365267
Cites Hum Mutat. 2011 Jun;32(6):E2176-88 21618343
Cites J Med Genet. 2011 Aug;48(8):523-5 21415078
Cites Fam Cancer. 2011 Sep;10(3):545-8 21614589
Cites Cancer. 2012 Mar 1;118(5):1362-70 21932393
Cites Hum Mutat. 2012 Apr;33(4):674-80 22241545
Cites Fam Cancer. 2012 Jun;11(2):235-42 22187320
Cites J Clin Oncol. 2012 Nov 10;30(32):e337-40 23032617
Cites Fam Cancer. 2012 Sep;11(3):483-91 22692731
Cites PLoS One. 2013;8(7):e67538 23935836
Cites PLoS One. 2013;8(8):e73638 23977390
Cites Breast Cancer Res. 2013;15(1):R17 23448497
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's
OTHERID SOURCE
PMC4065098 NLM